Theriva Biologics Inc (TOVX)
1.99
+0.53
(+36.30%)
USD |
NYAM |
Nov 01, 16:00
1.95
-0.04
(-2.01%)
After-Hours: 20:00
Theriva Biologics PS Ratio
PS Ratio Chart
Historical PS Ratio Data
| Date | Value |
|---|---|
| August 21, 2024 | 0.8853 |
| August 20, 2024 | 0.8981 |
| August 19, 2024 | 0.9474 |
| August 16, 2024 | 1.358 |
| August 15, 2024 | 1.348 |
| August 14, 2024 | 1.305 |
| August 13, 2024 | 1.394 |
| August 12, 2024 | 1.399 |
| August 09, 2024 | 1.466 |
| August 08, 2024 | 1.419 |
| August 07, 2024 | 1.404 |
| August 06, 2024 | 1.397 |
| August 05, 2024 | 1.324 |
| August 02, 2024 | 1.454 |
| August 01, 2024 | 1.474 |
| July 31, 2024 | 1.578 |
| July 30, 2024 | 1.879 |
| July 29, 2024 | 1.931 |
| July 26, 2024 | 1.872 |
| July 25, 2024 | 1.845 |
| July 24, 2024 | 1.958 |
| July 23, 2024 | 1.872 |
| July 22, 2024 | 1.796 |
| July 19, 2024 | 1.770 |
| July 18, 2024 | 1.863 |
| Date | Value |
|---|---|
| July 17, 2024 | 1.88 |
| July 16, 2024 | 1.899 |
| July 15, 2024 | 1.849 |
| July 12, 2024 | 1.757 |
| July 11, 2024 | 1.757 |
| July 10, 2024 | 1.763 |
| July 09, 2024 | 1.791 |
| July 08, 2024 | 1.703 |
| July 05, 2024 | 1.608 |
| July 03, 2024 | 1.554 |
| July 02, 2024 | 1.554 |
| July 01, 2024 | 1.631 |
| June 28, 2024 | 1.501 |
| June 27, 2024 | 1.544 |
| June 26, 2024 | 1.506 |
| June 25, 2024 | 1.515 |
| June 24, 2024 | 1.554 |
| June 21, 2024 | 1.525 |
| June 20, 2024 | 1.558 |
| June 18, 2024 | 1.557 |
| June 17, 2024 | 1.572 |
| June 14, 2024 | 1.633 |
| June 13, 2024 | 1.531 |
| June 12, 2024 | 1.528 |
| June 11, 2024 | 1.541 |
Price to Sales Ratio Definition
The Price to Sales Ratio (PS Ratio) is calculated by taking the stock price / revenue per share (ttm). This metric is considered a valuation metric that confirms whether the sales of a company justifies the stock price. There isn't necesarily an optimum PS ratio, since different industries will have different ranges of PS Ratios. Because of this, PS Ratio is great to evaluate from a relative standpoint with other similar companies. PS Ratio might also be a handy metric for companies that are not profitable yet, since they might be valued moreso by their overall sales and potential of becoming profitable in the future.
PS Ratio Range, Past 5 Years
0.8853
Minimum
Aug 21 2024
20.03
Maximum
Mar 18 2022
5.822
Average
3.931
Median
Nov 18 2022
PS Ratio Benchmarks
| BioCardia Inc | 9.068 |
| NovaBay Pharmaceuticals Inc | 0.0361 |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
| Oragenics Inc | 0.8841 |
PS Ratio Related Metrics
| Price to Book Value | 0.0772 |
| Price | 1.99 |
| Earnings Yield | -1.57K% |
| Market Cap | 2.000M |